Endometrial polyps: Current perspectives on epidemiology, pathogenesis, and treatment approaches
Aristotle University of Thessaloniki · 01.01.2026
DOI: 10.26262/heal.auth.ir.376229 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aristotle University of Thessaloniki, erschienen am 01.01.2026. Verfasst von Βέρα Μ. Κελεσίδου.
Abstract (Originalsprache)
Endometrial polyps are common endometrial lesions that may present with abnormal uterine bleeding, infertility, or be detected incidentally. This thesis reviews current evidence on their epidemiology, pathogenesis, diagnosis, treatment, recurrence, and clinical significance in special populations. The literature shows that although most endometrial polyps are benign, the risk of atypia or malignancy increases in postmenopausal women and in patients with additional risk factors such as obesity, tamoxifen use, and larger lesion size. Transvaginal ultrasound and saline infusion sonography are useful diagnostic tools, while hysteroscopy remains the gold standard for both diagnosis and treatment. Hysteroscopic polypectomy is the preferred management in symptomatic or high-risk cases, although controversy remains regarding the management of small asymptomatic polyps and their effect on fertility. Overall, better prospective studies are needed to improve risk stratification and guide individualized management.
Schlagwörter
Zitieren
APA
Κελεσίδου, Β. Μ. (2026). Endometrial polyps: Current perspectives on epidemiology, pathogenesis, and treatment approaches. Aristotle University of Thessaloniki. https://doi.org/10.26262/heal.auth.ir.376229
Vancouver
Κελεσίδου ΒΜ. Endometrial polyps: Current perspectives on epidemiology, pathogenesis, and treatment approaches. Aristotle University of Thessaloniki. 2026. doi:10.26262/heal.auth.ir.376229
BibTeX
@article{2026,
author = {Κελεσίδου, Βέρα Μ.},
title = {Endometrial polyps: Current perspectives on epidemiology, pathogenesis, and treatment approaches},
journal = {Aristotle University of Thessaloniki},
year = {2026},
doi = {10.26262/heal.auth.ir.376229}
}
EUVIMED